0000899243-21-000706.txt : 20210106 0000899243-21-000706.hdr.sgml : 20210106 20210106164144 ACCESSION NUMBER: 0000899243-21-000706 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210104 FILED AS OF DATE: 20210106 DATE AS OF CHANGE: 20210106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Snodgres Jon CENTRAL INDEX KEY: 0001613498 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 21511191 MAIL ADDRESS: STREET 1: REPLIGEN CORPORATION, 41 SEYON STREET STREET 2: BUILDING #1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02435 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-04 0 0000730272 REPLIGEN CORP RGEN 0001613498 Snodgres Jon C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 0 1 0 0 Chief Financial Officer Common Stock 2021-01-04 4 S 0 656 188.69 D 32799 D Common Stock 2021-01-04 4 S 0 1333 190.09 D 31466 D Common Stock 2021-01-04 4 S 0 202 190.50 D 31264 D Common Stock 2021-01-04 4 S 0 918 192.74 D 30346 D Common Stock 2021-01-04 4 S 0 218 193.88 D 30128 D Common Stock 2021-01-04 4 S 0 571 195.16 D 29557 D Common Stock 2021-01-04 4 S 0 59 195.77 D 29498 D Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 12, 2020. $188.69 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.14 to $189.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $190.09 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.45 to $190.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $192.74 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.37 to $193.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $193.88 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.37 to $193.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $195.16 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.71 to $195.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Jeffrey P. Leduc (Attorney in Fact) 2021-01-06